Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: J Pediatr. 2013 Feb 19;163(2):581–586. doi: 10.1016/j.jpeds.2013.01.015

Bereaved parents’ intentions and suggestions about research autopsies in children with lethal brain tumors

Justin N Baker 1, Jennifer A Windham 2, Pamela S Hinds 3, Jami S Gattuso 4, Belinda Mandrell 4, Poorna Gajjar 4, Nancy K West 4, Teresa Hammarback 4, Alberto Broniscer 5
PMCID: PMC3664241  NIHMSID: NIHMS435562  PMID: 23433673

Abstract

Objective

To determine bereaved parents’ perceptions about participating in autopsy-related research and to elucidate their suggestions about how to improve the process.

Study design

A prospective multicenter study was conducted to collect tumor tissue by autopsy of children with diffuse intrinsic pontine glioma (DIPG). In the study, parents completed a questionnaire after their child’s death to describe the purpose for, hopes (ie, desired outcomes of), and regrets about their participation in autopsy-related research. Parents also suggested ways to improve autopsy-related discussions. A semantic content analytic method was used to analyze responses and identify themes within and across parent responses.

Results

Responses from 33 parents indicated that the main reasons for participating in this study were to advance medical knowledge or find a cure, a desire to help others, and choosing as their child would want. Parents hoped that participation would help others or help find a cure as well as provide closure. Providing education/anticipatory guidance and having a trusted professional sensitively broach the topic of autopsy were suggestions to improve autopsy discussions. All parents felt that study participation was the right decision, and none regretted it; 91% agreed that they would make the choice again.

Conclusion

Because autopsy can help advance scientific understanding of the disease itself and parents reported having no regret and even cited benefits, researchers should be encouraged to continue autopsy-related research. Parental perceptions about such studies should be evaluated in other types of pediatric diseases.


Brain tumors are the second leading cause of death among children with cancer.1 Despite significant advances in the field of pediatric neuro-oncology, there has been little improvement in the outcome of children with some of the most lethal brain tumors, including diffuse intrinsic pontine glioma (DIPG).

New treatment approaches are badly needed for DIPG. Although targeted therapies have been successful in selected subsets of patients with other cancers whose tumors harbor specific genetic abnormalities,2, 3, little is known about the mechanisms of tumorigenesis in DIPG because tumor samples are rarely available for analysis.4 Therefore, a sound scientific rationale is lacking for the development of targeted therapies for childhood DIPG.

We and others have shown that tumor tissue obtained at autopsy from children with DIPG is suitable for extensive molecular studies.5, 6 However, many barriers limit pediatric autopsy for clinical and research purposes.7 Several studies have reported parents’ experiences with pediatric autopsies performed for clinical evaluation.8-12 Parents report that autopsies contribute to a better understanding of the factors contributing to their child’s death, of potential health implications for their other children, and of family planning considerations.8-14 In another study, however, a fairly large percentage (42%) of parents reported that their child’s autopsy added to their grief.15

Although the above studies explored parental perceptions and feelings associated with consent to autopsy of their child, parents’ reasons for and hopes (i.e., desired outcomes) of participating in research-related autopsy are unknown. Therefore, we conducted a study of parents’ hopes and purposes for participating in our multicenter autopsy study.

Methods

A prospective, multicenter institutional review board-approved study headed by investigators at St. Jude Children’s Research Hospital (St. Jude) was conducted to collect childhood DIPG tissue samples for detailed molecular analysis.5, 16 The specifics of this are reported elsewhere.5, 16 The current report addresses the study’s secondary objective of determining parents’ hopes and purposes for enrollment in the autopsy study. Eligible participants were the parents of a child with DIPG who consented to autopsy at the time of death as part of this protocol. After the autopsy findings were shared with families, parents were asked to complete a decisional regret survey and answer seven questions/statements by telephone interview or by completing a mail-in form (Table I).

Table I.

  1. Please share with us your reasons for deciding to participate in this study.

  2. Please share with us what you hope will happen for you, your family or others because of your/your child’s participation in this study.

  3. Would you offer any suggestions for a better way for us to discuss autopsies with family caregivers of children who have suffered and died from a brain tumor?

  4. What was good about participating in the autopsy study?

  5. What was disappointing or bad about participating in the autopsy study?

  6. Is there anything else you would like us to know?

  7. Would you like us to try to find professional support options in your community to assist you with your grief?

Qualitative Data Analysis

Qualitative semantic content analysis17 was performed on responses to 1, 2, and 3. Questions 4-7 were excluded from content analysis because few parents answered them and the responses were generally brief and lacked significant content. The unit of analysis within each response was the phrase, and each phrase was analyzed for meaning. Two study team members jointly reviewed the responses and applied codes to each key phrase to capture its meaning. Three other team members then completed study-specific training in semantic content analysis and independently analyzed the interviews. The mean inter-rater reliability of team members was 92.1% for question 1, 96.6% for question 2, and 96.3% for question 3.

The frequency of each code was tallied. To compensate for multiple occurrences of a code in a single interview, the percentage of parents for whom the code appeared was also tallied. For each question, multiple codes coincided frequently or overlapped in meaning. Such codes were grouped and identified as a theme that captured the shared meaning. As with the codes, the frequency of occurrence of each theme and the percentages of parents to whom each theme applied were tallied. The responses of St. Jude parents versus those of parents whose children were treated elsewhere were compared. Descriptive statistics were generated for responses to question 7.

Results

The parents of 38 consecutive children who underwent autopsy as part of the original research study were invited to complete this questionnaire. Thirty-three parents of 32 children consented (84.2% participation rate; 2 participants were parents of the same child). Eighteen of the children received treatment at St. Jude, and the remaining 14 received care at other institutions. The parents of these 14 children either contacted St. Jude directly or were referred to St. Jude for the autopsy study. The mean time from the child’s death to the parents’ completion of the questionnaire was 11 months (range, 2.9-35 months). Parents’ demographic data are summarized in Table II.

Table II.

Demographics of parents participating in the autopsy questionnaire study (n=33)

Time from
child’s
death to
parent’s
interview
Mean Median Range
Months 11.0 8.5 2.9-35
Education
level
Graduated
grade
school
Graduated
high
school
Completed
College
Completed
Graduaet
School
Left
blank
No. 3 12 13 2 3
Religion Protestant Muslim Jewish Catholic Other None Left
blank
No. 9 0 0 10 6 7 1
Marital
status
Married Single Divorced or
separated
Other Left
blank
No. 22 7 3 0 1
Child’s
treatment
location
St. Jude# Other
No. 19 14
#

St. Jude Children’s Research Hospital

All parents reported that participating in the study was the right decision and that they did not regret it. Specifically, 91% strongly agreed or agreed that they would make the choice again; 88% did not think participating did a lot of harm, and 97% felt it was a wise decision (Table III).

Table III.

Decisional regret about participation in an autopsy-related research study among bereaved parents of children with diffuse intrinsic pontine glioma

It was the
right decision
I regret the
choice that
was made
I would go
for the
same choice
if I had to
do it over
again
The choice
did a lot of
harm
The decision
was a wise
one
Strongly agree 31 (94%) 0 27 (82%) 0 27 (82%)
Agree 2 (6%) 0 3 (9%) 1 (3%)a 5 (15%)
Neutral 0 1 (3%) 1 (3%) 3 (9%) 1 (3%)
Disagree 0 5 (15%) 0 6 (18%) 0
Strongly
disagree
0 27 (82%) 0 23 (70%) 0
Left blank 0 0 2 (6%) 0 0
Comments “It was the
right thing to
do. If you can
help find a
cure for
cancer you
must give
everything you
can to that
cause.”
“I believe we
made the best
choice
possible
during such a
traumatic time
in our lives. I
would only
encourage
other families
to also donate
the tumor that
has affected
their lives!”
“I feel that I
would do it
again for the
reason that
if you can
help the
next person
then why
not.”
“The choice
did no harm.
… my
daughter
looked
beautiful at
her funeral.”
“It was the
only choice
that made
sense after
watching our
son die. I
hope our
son’s gift
helps to find
a cure.”
a

Parent quote revealed that this response referred to the child’s therapeutic trial, not the autopsy trial.

Parents’ responses to questions 1, 2, and 3 generated 75, 51, and 74 unique codes, respectively. The grouping of codes with similar meanings generated 7, 5, and 13 themes, respectively (Tables IV and V). When asked about their reasons for consenting to autopsy (question 1), parents most frequently mentioned their wish to advance knowledge or find a cure, a desire to help others, and choosing as their child would want. When asked about what they hoped would happen as a result of the study (question 2), parents reported hoping that participation would help others, help find a cure, and help provide closure for their family (the term closure was introduced without definition by participants). When asked for suggestions to improve the autopsy discussion (question 3), parents most frequently suggested providing education/anticipatory guidance, having a trusted professional sensitively broach the topic, and understanding each family’s needs and preferences when conducting these discussions.

Table IV.

Question 1: “Please share with us your reasons for deciding to participate in this study.”
Theme Theme definition #
codes
(%)
#
parents
(%)
Example quotations
Wanting to help others Parent was asked or desired to “give back” so that other families might be
spared the loss of their child or other children might not suffer and die.
24
(32.9)
24
(72.7)
“Another family won’t have to go through what we did.”
Wanting to advance
knowledge or find a cure
Parent recognized participation as a rare opportunity to assist in advancing
understanding of this tumor and improving disease outcomes.
35
(47.9)
22
(66.7)
“We want to help in the battle against pediatric brain cancer
every way we can.”
Choosing as our child
would want
Parent believed that the deceased child would have wanted the parent to
donate the tumor sample.
6 (8.2) 6 (18.2) “It’s what our son would have wanted.”
Frustrated at inability to
help child
Parent recalled feeling helpless at being unable to provide a cure for their
child and/or viewed this study as the only action they could take.
4 (5.5) 3 (9.1) “It’s frustrating to feel so helpless when your young child is
counting on you!”
Finding meaning in
tumor donation
Parent believed that including the child’s tissue in the study allowed them
to help make a difference that may be part of a greater plan.
2 (2.7) 2 (6.1) “If her tissue donation was God’s reason for taking her to Heaven
so soon, then far be it from me to prevent that from happening.”
Our child does not need
that tissue
Parents reported that their child was not hurt by the autopsy and/or their
faith indicated to them that their child was not contained within the body.
1 (1.4) 1 (3) “And he doesn’t need that tissue now.”
Learning results of
autopsy study
Parent had a personal desire to participate in the study to gain information
about the child’s tissue analysis and the overall study findings.
1 (1.4) 1 (3) “We offered this … to learn the results of such a study.”
Question 2: “Please share with us what you hoped would happen for you, your family or others because of your/your child’s participation in the study.”
Theme Theme definition #
codes
(%)
#
parents
(%)
Example quotations
Hope for a cure Parent was motivated by a desire to improve the understanding of gliomas
and perhaps ultimately to prevent or cure the disease.
33
(64.7)
26
(78.8)
“I hope they can come up with a cure.”
Hope to help others Parent hoped their participation might help other parents, patients, and
families avoid the suffering and loss of a child to this disease or hoped to
contribute in some way.
11
(21.6)
11
(33.4)
“I feel good knowing that it could help to prevent this from
happening to another child and their family.”
Hope for closure Parent was motivated by a desire to promote the emotional recovery of
self and family.
5 (9.8) 5 (15.2) “That would bring closure to me and my family.”
Benefit from earlier
research participation
Parent had had a positive experience when participating in earlier studies. 1 (2) 1 (3) “We got to participate in a wonderful study that helped our
daughter live a much better quality of life. “
Hope to know of study
findings
Parents hoped to learn about the research outcomes and the impact of
their child’s contribution on these outcomes.
1 (2) 1 (3) “I also hope (expect) to be kept updated as to the findings of this
study. Regardless of whether the findings are positive or
negative, I want to be informed of the results.”

Table V.

Question 3: “Would you offer any suggestions for a better way for us to discuss autopsies with family caregivers of children who have suffered and died from a brain tumor?”

Theme Theme definition No. of
codes (%)
n = 74
No. of
parents
(%)
n = 33
Example quotation
Finding
meaning in
child’s death
by helping
others
Parents indicated that an
explanation of our purpose for
research was helpful and gave them
a rare opportunity to help others
and to find meaning in their child’s
death and autopsy.
9 (12.2) 8 (24.2) “While we understand the need, we
have a desire to know that our
daughter’s loss was one that may
offer hope to others. I’d like to
think that her death meant
something.”
Autopsy
discussion and
process was
fine
Parents were satisfied with the
entire autopsy experience.
8 (10.8) 8 (24.2) “We think that you did a great job
explaining what you could to us.”
Inform others Some parents had known about the
study and suggested proactively
informing other health care
providers about the study and using
novel outside resources, such as
other parents, to get the word out.
10 (13.5) 8 (24.2) “I found out about the study and
brought it to the doctor’s
attention.”
Be mindful of
timing
Parents understood that autopsy
must be discussed but felt that the
health care provider should be
sensitive about when to bring up
the topic with families.
10 (13.5) 7 (21.2) “I know the difficult part for all of
the doctors is the trouble with
finding the right timing to bring this
up.”
This is hard Parents expressed awareness that it
is difficult to know what to do and
that there is no good way to
approach the autopsy discussion.
7 (9.5) 6 (18.2) “I don’t think there will ever be a
better way to discuss the death of
their child.”
Caring request Parents suggested that staff should
be kind, considerate, and
sympathetic when approaching
families about autopsy research and
should choose words and phrases
that provide maximal comfort to
the family when discussing death.
6 (8.1) 5 (15.2) “We were comforted by his
kindness.”
Let us know
what to expect
Parents suggested that providing
information about the autopsy
process/procedure would help with
the decision.
6 (8.1) 5 (15.2) “We were a little uncertain on what
was actually being removed, but
when we asked more questions we
got a better description.”
Having a
consistent
relationship
with the health
care provider
Parents felt that it was important to
have an ongoing connection
throughout the disease course with
the physician who will discuss
autopsy with them.
4 (5.4) 4 (12.1) “If the choice had not been made
before death, the discussion should
be with the attending physician
leading.”
Facilitate the
process
All aspects of the autopsy should be
coordinated.
4 (5.4) 4 (12.1) “We did not have the necessary
paperwork completed prior to my
daughter’s death. She died late on a
Saturday night and it was very
difficult and time-consuming to get
all the papers in order and the
appropriate hospital contacted so
that the biopsy could be performed.
It would have been easier if we had
this arranged while at St. Jude.”
Child will be
presentable
Parents need to be reassured that
their child will not be disfigured by
the autopsy and can have an opencasket
funeral.
3 (4.1) 3 (9.1) “It was a comfort to us and I think it
will be to parents to learn that you
can still have an open casket and no
one can tell that your child had an
autopsy.”
Wanting to
know findings
Parents suggested that it would be
helpful to provide autopsy results,
which may validate their decision to
enroll in the study.
4 (5.4) 2 (6.1) “In particular, I would like to learn
the findings of such studies and
when the tumors were analyzed. “
Each family has
individual
needs
Health care providers should
understand and consider each
family’s cultural and spiritual
beliefs, as families are unique in the
way they handle circumstances.
2 (2.7) 2 (6.1) “It depends on the family because
each family takes it all differently. ”
Telephone
request is
acceptable
Parents felt that it would be
appropriate to telephone the
parents of a child to discuss
participation in autopsy-related
research.
1 (1.4) 1(3) “And if they don’t respond to the
mailing, it is OK to call them.
Parents would agree to discuss it.”

We compared the responses to questions 1-3 that were given by parents of patients treated at St. Jude with those of parents whose children were treated at other institutions. For question 1, the theme of helping others was more frequent in the St. Jude cohort (73.7%) than in parents of patients treated at other institutions (42.9%). For question 3, the theme of finding meaning in the child’s death was less frequent in the St. Jude cohort (10.5%) than at other institutions (48.9%). No other site-associated differences were noted.

A total of 10 of 33 (30.3%) parents responded that they had already been in contact with bereavement resources. However, 5 (21.7%) of the remaining 23 parents reported a need for bereavement follow-up or resources in their response to question 7.

Discussion

This is study assessed the purposes and hopes of bereaved parents who consent to a research-related autopsy of their child. As in other autopsy-related studies8, 18, a large percentage of the parents in our study consented to autopsy because of a desire to help other children and families avoid the suffering and loss of a child to this disease and to help other parents know that they are not alone. These reasons, coupled with parents’ strong sense of altruism, may partly explain the absence of regret about consenting to their child’s autopsy. Furthermore, in our clinical experience, almost all parents retain an ongoing positive feeling about their experience in the autopsy study, even after a long period of follow-up.

Although parents’ perceptions about their child’s autopsy are not widely reported, most findings indicate little or no parental regret about the decision to participate in autopsy-related studies.12, 18 Parents have reported that consenting to their child’s autopsy helped them during the grieving process.8, 11 However, Sullivan and Monagle recently found that 42% of bereaved parents reported that their child’s autopsy added to their grief, although 90% valued autopsy as a means of finding out why their child died.15 Their study sample differed profoundly from ours. Although our study included only parents of children who died of DIPG, the other included parents whose children had died of diverse reasons, including accidents, acute illness, chronic illness, and disability. All of the autopsies were performed for clinical rather than research reasons, providing parents no opportunity for altruism, and many were legally mandated with or without parental consent, possibly adding to parents’ grief.

In contrast, none of the parents in our study reported decisional regret, and all reported that they would consent to autopsy again. Children with DIPG have a grim prognosis and a predictable disease progression, and their parents must inevitably face the reality of their child’s death early in the disease trajectory. These parents have formed strong relationships with the medical team, and most have previously enrolled their child in a clinical trial. These families have come to understand the benefits of research and may be more likely to view the autopsy and related research in an altruistic framework.

Parents’ purposes and hopes did not differ by primary treatment site, with the exception of the purposes of helping others (more prevalent at St. Jude) and of finding meaning (more prevalent at other sites). These differences may reflect the immersion of families at St. Jude in a research environment. In contrast, parents at other sites were self-selected. The consistency of the remaining themes across the three questions and across treatment sites suggests that these themes broadly reflect the perspectives of bereaved parents of children with DIPG. Although DIPG differs from some other diseases in that it has a dismal prognosis at the point of diagnosis, many of these themes are likely to apply to the parents of children who die of other pediatric diseases.

Approaching parents for consent to autopsy, either before or (more frequently) immediately after death, can be a challenging experience for both the physician and the family members. Parents report that they find the initial discussion of autopsy disturbing, brief, clinical, and lacking in detail.8, 9, 15 These responses point to the need for longer discussions and more detailed explanations. Parents in our study, when asked how clinicians could better discuss autopsy, gave several thoughtful and specific suggestions (Table V) that can be implemented clinically to improve the way families are approached. They also suggested that although this discussion must be sensitively timed, it need not be postponed until after the child’s death.

Parents’ suggestions also reveal that the discussion was better tolerated when the physician was one they had a relationship with and who showed concern. Consistent and credible care by the medical staff were also significant factors in how parents perceived the autopsy discussion. One parent was approached about autopsy by a staff member who had consistently cared for her child. She described the discussion as genuine, thoughtful, and considerate, noting that she would not have changed a thing.

Parents also noted that there is no right time to bring up the topic of autopsy. They appeared to understand the difficulty experienced by medical staff in finding the most appropriate time, as exemplified by the comment, “I know the difficult part for all of the doctors is the trouble with finding the right timing to bring this up.” Many parents stated that they would have preferred an earlier discussion, whereas others felt that this idea was unhelpful and offered less comfort. Parents agreed that the child’s primary physician should initiate the autopsy discussion in a manner consistent with the needs of individual parents. The parents’ theme of “Each family has individual needs” further illustrates the importance of taking an individualized approach when having these discussions.

Parents also expressed the need to receive clear, concrete information about the autopsy procedure. Not knowing the specific details of the process can lead to marked anxiety.9 The physician who asks for consent can reduce this anxiety by spending the necessary time to describe the concrete steps of the autopsy process in detail. Parents stated that knowing what to expect significantly alleviated their concerns about providing consent. For example, they reported that knowing details about what specifically will be removed during autopsy and whether the child’s body will remain presentable for funeral planning were helpful.

Although parents did not specifically suggest grief and bereavement services, several parents in the study reported contact with bereavement resources of some kind, and some of the remaining parents reported a need for additional bereavement follow-up or resources. Therefore, these parents have an ongoing need for assessment of grief and bereavement-related issues, and a coordinated institutional effort should be made to allocate resources to include bereavement care planning in end-of-life care plans.

Our study was limited by the fact that some potential participants could not be contacted and the primary team recommended that someothers not be approached; these potential participants had undergone the same experience but may have had perspectives that differed from those reported. Furthermore, because this was a cross-sectional study conducted at a single point in time, it is unclear whether parents’ perspectives change over time. Our study included only the parents of children who died of DIPG; this factor limits the generalizability of our findings because most families face the reality of their child’s impending death later in the disease trajectory than do parents of children with DIPG and, therefore, may have different perspectives. Still, the parental experiences reported here should help to inform future autopsy-related research in pediatrics. Because autopsy can advance scientific understanding of the disease itself and because parents reported having no regret and even cited benefits, researchers should be encouraged to promote autopsy-related research. Parental perceptions about such studies should be evaluated in other pediatric diseases.

Acknowledgments

Supported by the Cancer Center (5P30CA021765-32), Tyler’s Treehouse Foundation, and the American Lebanese Syrian Associated Charities.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

The authors declare no conflicts of interest.

Reference List

  • (1).Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49. doi: 10.3322/caac.20006. [DOI] [PubMed] [Google Scholar]
  • (2).Blay JY. A decade of tyrosine kinase inhibitor therapy: historical and current perspectives on targeted therapy for GIST. Cancer Treat Rev. 2011;37:373–84. doi: 10.1016/j.ctrv.2010.11.003. [DOI] [PubMed] [Google Scholar]
  • (3).Kim LC, Rix U, Haura EB. Dasatinib in solid tumors. Expert Opin Investig Drugs. 2010;19:415–25. doi: 10.1517/13543781003592097. [DOI] [PubMed] [Google Scholar]
  • (4).Jansen MH, van Vuurden DG, Vandertop WP, Kaspers GJL. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treat Rev. 2012;38:27–35. doi: 10.1016/j.ctrv.2011.06.007. [DOI] [PubMed] [Google Scholar]
  • (5).Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, et al. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol. 2011;29:3999–4006. doi: 10.1200/JCO.2011.35.5677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (6).Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A, et al. Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol. 2010;28:1337–44. doi: 10.1200/JCO.2009.25.5463. [DOI] [PubMed] [Google Scholar]
  • (7).Spunt SL, Vargas SO, Coffin CM, Skapek SX, Parham DM, Darling J, et al. The clinical, research, and social value of autopsy after any cancer death: a perspective from the Children’s Oncology Group Soft Tissue Sarcoma Committee. Cancer. 2012;118:3002–9. doi: 10.1002/cncr.26620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).Beckwith JB. The value of the pediatric postmortem examination. Pediatr Clin North Am. 1989;36:29–36. doi: 10.1016/s0031-3955(16)36614-7. [DOI] [PubMed] [Google Scholar]
  • (9).Berger LR. Requesting the autopsy: a pediatric perspective. Psychosocial and professional aspects of the autopsy in caring for the dying child and his family. Clin Pediatr (Phila) 1978;17:445–52. doi: 10.1177/000992287801700511. [DOI] [PubMed] [Google Scholar]
  • (10).Brodlie M, Laing IA, Keeling JW, McKenzie KJ. Ten years of neonatal autopsies in tertiary referral centre: retrospective study. BMJ. 2002;324:761–3. doi: 10.1136/bmj.324.7340.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (11).McPhee SJ, Bottles K, Lo B, Saika G, Crommie D. To redeem them from death. Reactions of family members to autopsy. Am J Med. 1986;80:665–71. doi: 10.1016/0002-9343(86)90822-3. [DOI] [PubMed] [Google Scholar]
  • (12).Rankin J, Wright C, Lind T. Cross sectional survey of parents’ experience and views of the postmortem examination. BMJ. 2002;324:816–8. doi: 10.1136/bmj.324.7341.816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (13).Meert KL, Eggly S. Follow-up after a child’s death in the pediatric intensive care unit: Can it improve family outcomes? Pediatr Crit Care Med. 2011;12:676–7. doi: 10.1097/PCC.0b013e3182076d5d. [DOI] [PubMed] [Google Scholar]
  • (14).Meert KL, Eggly S, Berger J, Zimmerman J, Anand KJ, Newth CJ, et al. Physicians’ experiences and perspectives regarding follow-up meetings with parents after a child’s death in the pediatric intensive care unit. Pediatr Crit Care Med. 2011;12:e64–8. doi: 10.1097/PCC.0b013e3181e89c3a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (15).Sullivan J, Monagle P. Bereaved parents’ perceptions of the autopsy examination of their child. Pediatrics. 2011;127:e1013–20. doi: 10.1542/peds.2009-2027. [DOI] [PubMed] [Google Scholar]
  • (16).Broniscer A, Baker JN, Baker SJ, Chi SN, Geyer JR, Morris EB, et al. Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma. Cancer. 2010;116:4632–7. doi: 10.1002/cncr.25405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (17).Krippendorf K. Content analysis: an introduction to its methodology. SAGE Publications; Newbury Park, CA: 1980. [Google Scholar]
  • (18).McHaffie HE, Fowlie PW, Hume R, Laing IA, Lloyd DJ, Lyon AJ. Consent to autopsy for neonates. Arch Dis Child Fetal Neonatal Ed. 2001;85:F4–7. doi: 10.1136/fn.85.1.F4. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES